WALL, N.J., Feb. 21, 2011 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in finger-based biometric identification solutions, today announced that its biometric software will be represented by the Company's channel partners and integrators at the HIMSS11 at the Orange County Convention Center in Orlando, Florida February 20-24, 2011.
The Healthcare Information and Management Systems Society (HIMSS), is the healthcare industry's membership organization, and hosts a number of events and conferences in the United States and internationally. The conference presents a forum for education and knowledge, along with the opportunity to network and meet with other healthcare IT professionals who are influencing the world of healthcare IT today.
Attendees of the conference will have the opportunity to witness BIO-key's finger based biometric technology by visiting BIO-key technology partner exhibits such as Lumidigm (Booth#5242), Healthcast (Booth #1342) and Cherry (Booth #2135). EHR providers Allscripts-Sunrise Clinical Manager & Enterprise EHR (Booth #2241), EPIC (Booth#3063) and healthcare partner McKesson (Booth#6471) will also be exhibiting at the conference and have integrated BIO-key software into their security solutions platform. Also, to learn more about BIO-key solutions for ESSO, visit the IBM (Booths #3763 & #3769), Oracle (Booth#1651) and Sentillion, a Microsoft Company (Booth#3101) booths in the exhibit hall.
"The HIMSS conference enables us to learn more about the needs of our partners and their end users, along with the latest trends in the healthcare industry. The dynamic exchanges with partners will often lead to new product development concepts to address the growing demand for strong authentication in the medical industry," stated Mike DePasquale, CEO, BIO-key International.
The advanced level of education which takes place in the Symposiums and workshops makes the HIMSS conference a premier event within the healthcare industry. This year's event will offer over 300 sessions focused on the industry's hottest topics: Meaningful Use, HITECH, HIE, standards, interoperability and more.
"In healthcare, BIO-key's track record for compliance, meeting regulatory standards and performance excellence has allowed us to significantly expand our scope of partners and end-users. Our VST and WEB-key platform software offers universal compatibility with all of the major finger print reader manufacturers, this feature combined with our seamless unlimited scalability has positioned us as the consummate partner for finger based biometric technology in healthcare," said Randy Fodero, VP Sales. "The healthcare industry continues to face challenges with authentication and identification, privacy and access to patient records. Finger based biometrics has proven to deliver extremely accurate authentication that can't be compromised yet offers unmatched convenience. Simply put, we believe BIO-key has a finger on the future of compliant – secure – identity solutions," offered Fodero.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.